Werfen

A Specialized Diagnostics leader, Werfen delivers Hemostasis, Acute Care, Autoimmunity, and OEM solutions to Power Patient Care. In 2023, we acquired Immucor, adding Transfusion and Transplant to our portfolio. Key products: ACL TOP^® Family 50 Series, HemosIL^® assays, HemoHub^®; GEM^® Premier™ 5000, GEM Premier ChemSTAT^®, GEM Hemochron™ 100, ROTEM^® sigma, VerifyNow™, GEMweb^® Plus 500; Aptiva^®, BIO-FLASH^®, QUANTA-Lyser^®, QUANTA-Link^®; Echo Lumena^®, NEO Iris^®; assays/biomat for IVD industry.

For more information visit our website: https://www.werfen.com/na/en